— Know what they know.
Not Investment Advice

IRWD NASDAQ

Ironwood Pharmaceuticals, Inc.
1W: +4.9% 1M: -7.9% 3M: -2.8% YTD: -9.8% 1Y: +490.1% 3Y: -61.9% 5Y: -67.0%
$3.92
+0.07 (+1.82%)
 
Weekly Expected Move ±12.2%
$3 $3 $4 $4 $4
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Sell · Power 40 · $645.3M mcap · 158M float · 1.79% daily turnover · Short 52% of daily vol

📊 Key Metrics

TTM
$362M
Revenue
+13.8% YoY
$102M
Net Income
+415.9% YoY
$112M
Free Cash Flow
+43.1% YoY
99.6%
Gross Margin
68.1%
Op. Margin
38.3%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-36.3%
ROA27.3%
ROIC98.8%

Valuation

P/E6.2
P/B-2.9
EV/EBITDA4.7

Leverage

Debt/Equity-2.28
Current Ratio1.13
Interest Cov.6.0x

Quality Scores

Piotroski F7/9
Altman Z-2.67
Beneish M-2.36

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms